render_searchpagetitle(); ?> render_searchpagemetatags(); ?>
Search - Add URL - Join The Lab
Found 7712 results for any of the keywords trials were. Time 0.022 seconds.
Soil Aeration, SoilM8, Soil Decompaction Research TrialsWe have moved on a long way since these trials were done.
Cancer Centers Measure COVID-19 Impact on Clinical TrialsDiscover the Latest News in Clinical Research, Clinical Trials, Medical Informatics, More. Clinical Research News Online Provides Daily Insights, News, Analysis for the Clinical Research Industry.
SKYRIZI® (risankizumab-rzaa) for PsA and Ps - RheumatologyExplore SKYRIZI®, a biologic treatment for adults with active psoriatic arthritis. See benefits, risks, and important safety information.
SKYRIZI® (risankizumab-rzaa) for Ps and PsA - DermatologyExplore SKYRIZI® (risankizumab-rzaa), a biologic treatment for adults with moderate to severe plaque psoriasis and for adults with active psoriatic arthritis. See benefits, risks, and important safety information.
Rheumatoid Arthritis Treatment | RINVOQ® (upadacitinib)View info for healthcare professionals about RINVOQ®, a treatment for moderate to severe rheumatoid arthritis (RA) in adult TNFi-IR patients. See Important Safety Information, including BOXED WARNING.
Psoriatic Arthritis Treatment | RINVOQ® (upadacitinib)View information for healthcare professionals about RINVOQ®, a treatment for active psoriatic arthritis in adult TNFi-IR patients. See Important Safety Info, including BOXED WARNING.
Crohn s Disease Treatment | RINVOQ® (upadacitinib)View information for healthcare professionals about RINVOQ®, a treatment for moderately to severely active Crohn s disease in adult TNFi-IR patients. See Important Safety Info, including BOXED WARNING.
Axial Spondyloarthritis | RINVOQ® (upadacitinib)View info for healthcare professionals about RINVOQ® for active ankylosing spondylitis or non-radiographic axial spondyloarthritis in adult TNFi-IR patients. See Important Safety Info, including BOXED WARNING.
RINVOQ® (upadacitinib) for Atopic DermatitisLearn about RINVOQ®, a JAK inhibitor for the treatment of adults and pediatric patients with refractory, moderate to severe atopic dermatitis. See full Prescribing and Safety Information, and BOXED WARNING.
RINVOQ® (upadacitinib) | Official Healthcare Professional SiteRINVOQ® (upadacitinib) is approved for treatment of certain patients with RA, PsA, AD, UC, AS, nr-axSpA, and CD. See full Prescribing, Use Safety Info, and BOXED WARNING
|
Sponsored Results
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less | ||
To process your query we did a search for the keyphrases trials, trials were << Previous - 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - Next >> |
Didn't find what you were searching for? You can add a new website to the index, remove your site from the search results using the robots.txt protocol or tell us how you would like the results by sending us a message using the email address below:
|
Recent searches:
business ideas in pakistan - expeed software - zubee com - appliance repair winnipeg - birla ojasvi
pokemon - Chantelle - cancer conference - rsg fasteners - shri ram ias
Copyright (C) 2007 - 2024 Text Ad King and SecretSearchEngineLabs.com. All Rights Reserved.
Terms and Conditions - Privacy Policy - Advertising - About Us - Login